Wang Jiaxi, Lu Humu, Fang Wenxuan, Lin Miaoping, Feng Yuyao, Qi Xin, Gao Chenghai, Liu Yonghong, Wang Xueni, Luo Xiaowei
Guangxi Key Laboratory of Marine Drugs, University Engineering Research Center of High-efficient Utilization of Marine Traditional Chinese Medicine Resources, Guangxi Institute of Marine Drugs, Guangxi University of Chinese Medicine Nanning 530200 China
Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine Nanning 530200 China
RSC Adv. 2024 Dec 9;14(52):38697-38705. doi: 10.1039/d4ra06292b. eCollection 2024 Dec 3.
Four novel resorcylic acid lactones (RALs), curvulomycins A-D (1-4), and six known congeners were isolated from the Beibu Gulf coral-derived fungus GXIMD 02512. Their structures including absolute configurations were established by extensive spectroscopic analyses along with experimental and calculated ECD spectra. Structurally, compound 3 harbors a unique γ-pyrone moiety rarely found in the natural RAL family. Notably, curvulomycin D (4) represents the first reported compound of the rare 8-membered RAL derivatives. Compounds 1 and 5 exhibited significant antiproliferative potency against two prostate cancer cell lines, with IC values of 9.70 ± 0.77 μM and 7.64 ± 0.46 μM for PC-3 cells and 5.96 ± 0.43 μM and 3.15 ± 0.27 μM for 22Rv1 cells, respectively. Moreover, compound 1 inhibited clonal cell colonies in a dose-dependent manner, blocked the S and G2 phases in the PC-3 cell cycle and the G1 phase in the 22Rv1 cell cycle, which further induced apoptosis in both PC-3 and 22Rv1 cells, indicating its potential as a promising lead compound for anti-prostate cancer therapy.
从北部湾珊瑚来源的真菌GXIMD 02512中分离出4种新型间苯二酚内酯(RALs),即弯孢霉素A-D(1-4),以及6种已知的同系物。通过广泛的光谱分析以及实验和计算的ECD光谱确定了它们的结构,包括绝对构型。在结构上,化合物3含有一个在天然RAL家族中很少见的独特γ-吡喃酮部分。值得注意的是,弯孢霉素D(4)是首次报道的罕见的8元RAL衍生物化合物。化合物1和5对两种前列腺癌细胞系表现出显著的抗增殖活性,对PC-3细胞的IC值分别为9.70±0.77μM和7.64±0.46μM,对22Rv1细胞的IC值分别为5.96±0.43μM和3.15±0.27μM。此外,化合物1以剂量依赖性方式抑制克隆细胞集落,阻断PC-3细胞周期中的S期和G2期以及22Rv1细胞周期中的G1期,这进一步诱导了PC-3和22Rv1细胞的凋亡,表明其作为抗前列腺癌治疗有前景的先导化合物的潜力。